| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | Australia | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | Hong Kong | 2 | |
| #7 | Israel | 2 | |
| #8 | New Zealand | 2 | |
| #9 | WIPO (World Intellectual Property Organization) | 2 | |
| #10 | South Africa | 2 | |
| #11 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Goldberg Joshua | 21 |
| #2 | Bier Colin | 21 |
| #3 | Hanscom Sophie | 11 |
| #4 | Hotz-Behofsits Christoph | 11 |
| #5 | Cohen David I | 5 |
| #6 | Joshua Goldberg | 3 |
| #7 | Colin Bier | 3 |
| #8 | Sophie Hanscom | 2 |
| #9 | Christoph Hotz-Behofsits | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2014329393A1 | Immunostimulatory HIV Tat derivative polypeptides for use in cancer treatment | |
| CA2894166A1 | Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides | |
| AU2010230073A1 | Treatment of cancer with immunostimulatory HIV Tat derivative polypeptides |